Galectin‐3 and histological, molecular and biochemical aspects of myocardial fibrosis in heart failure of hypertensive origin

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|17|4|385-392

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.17, Iss.4, 2015-04, pp. : 385-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eplerenone‐Mediated Regression of Electrical Activation Delays and Myocardial Fibrosis in Heart Failure

By  

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, Vol. 25, Iss. 5, 2014-05 ,pp. : 537-544

John Wiley & Sons Inc

Access to resources Recommend Favorite

Circulating Galectin-3 Levels Are Increased in Patients with Ischemic Heart Disease, but Are Not Influenced by Acute Myocardial Infarction

By  

Cardiology, Vol. 134, Iss. 4, 2016-04 ,pp. : 398-405

Karger

Access to resources Recommend Favorite

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction

By de Boer Rudolf A.   Lok Dirk J. A.   Jaarsma Tiny   van der Meer Peter   Voors Adriaan A.   Hillege Hans L.   van Veldhuisen Dirk J.  

Annals of Medicine, Vol. 43, Iss. 1, 2011-02 ,pp. : 60-68

Informa Healthcare

Access to resources Recommend Favorite

Galectin‐3 in patients with heart failure with preserved ejection fraction: results from the Aldo‐DHF trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 2, 2015-02 ,pp. : 214-223

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 3, 2015-03 ,pp. : 263-272

John Wiley & Sons Inc

Access to resources Recommend Favorite